Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 41.00
Ask: 42.00
Change: -2.00 (-4.60%)
Spread: 1.00 (2.439%)
Open: 43.50
High: 43.50
Low: 41.50
Prev. Close: 43.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio News - Molendotech Collaboration

29 Jan 2018 07:00

RNS Number : 1274D
Frontier IP Group plc
29 January 2018
 

 

 

 

 

Frontier IP Group Plc

 

Portfolio News - Molendotech Collaboration with Palintest

 

 

Frontier IP, which specialises in the commercialisation of university intellectual property, is pleased to announce that portfolio company Molendotech Limited ("Molendotech"), a spin-out company from the University of Plymouth, has entered into a collaboration agreement with Palintest Limited ("Palintest"), a subsidiary of FTSE company Halma plc, for the development and licencing of water testing products.

 

Molendotech has developed a novel test which is able to identify the concentration of faecal bacteria in water. Molendotech's rapid, point-of-use test to determine water quality enables more informed decision-making about the use of water and significantly improves the ability to identify and track any pollution source. Molendotech now aims to bring its product to market and to develop further products for the water testing market, in collaboration with Palintest.

 

Professor Simon Jackson, Director of Molendotech, said, "We are delighted to announce our collaboration with Palintest, a market leader in water testing products. We are looking forward to working with Palintest to accelerate getting our products to market."

 

Simon Bowman, Technical Director of Palintest, said, "We are very excited to be working with the Molendotech team and pleased to bring our own know-how and expertise to develop and commercialise the Molendotech technology."

 

Neil Crabb, Chief Executive of Frontier IP, said, "Molendotech is showing strong potential and its technology is capable of addressing a wide range of water-testing applications from beaches to the beverage industry."

 

For further information:

 

Frontier IP Group Plc

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

T: 0131 240 1251

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Neil McDonald / Beth McKiernan

T: 0131 220 6939

Peterhouse Corporate Finance Limited (Joint Broker)

Lucy Williams

T: 020 7469 0935

Kreab (Financial PR)

Robert Speed / Matthew Jervois

T: 020 7074 1800

 

Notes to Editor:

 

About Frontier IP Group plc

 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.

 

About Molendotech

 

Molendotech was created to develop and commercialise the work of Simon Jackson, Professor of Environment and Human Health within the Plymouth University, Peninsula Schools of Medicine and Dentistry. Molendotech develops a rapid assay to screen water for faecal contamination. Current tests on the market may take hours or even days to show results, whereas Molendotech's technology typically produces results in under 15 minutes. A patent has been filed in relation to the technology, which has already been granted in the US for recreational waters.

 

About Palintest

 

Palintest is a world-leading manufacturer of water testing kits and environmental products for water quality analysis in drinking water, Pools and Spas, waste water and effluent. Palintest is a wholly owned subsidiary of the FTSE 100 company Halma plc, which employs over 5,800 people in around 50 businesses, based in more than 20 countries, with major operations in Europe, USA and Asia.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEANFPAELPEFF
Date   Source Headline
25th Nov 20222:23 pmRNSDirector/PDMR Shareholding
23rd Nov 20225:17 pmRNSDirector share transfers
18th Nov 20223:53 pmRNSExercise of Options & PDMR Shareholdings
11th Nov 20223:07 pmRNSDirector/PDMR Dealing
11th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
8th Nov 20227:00 amRNSPulsiv announces £1.5m fundraise
1st Nov 20221:46 pmEQSFrontier IP Group 'rigged for a storm' but confident of more progress
27th Oct 20227:00 amRNSFinal Results
19th Oct 20224:22 pmRNSHolding(s) in Company
19th Oct 20223:29 pmRNSHolding(s) in Company
14th Oct 20227:00 amRNSElute Intelligence appoints Steve Cable as CEO
27th Sep 20227:00 amRNSPulsiv unveils power electronics technology
18th Aug 20223:20 pmRNSSale of shares in Exscientia
5th Aug 20227:00 amRNSCamGraPhIC announces £1.26 million fundraising
26th Jul 20224:26 pmRNSHolding(s) in Company
26th Jul 20224:07 pmRNSHolding(s) in Company
24th May 20227:00 amRNSCambridge Raman Imaging raises £1.1 million
19th May 20227:00 amRNSPublication of newsletter
12th Apr 20225:18 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSUnaudited Half Year Results
14th Feb 20227:00 amRNSSale of shares in Exscientia
11th Feb 20225:04 pmRNSHolding(s) in Company
11th Feb 20222:05 pmRNSHolding(s) in Company
10th Feb 20227:00 amRNSCambridge Raman Imaging wins European Union grant
25th Jan 20227:00 amRNSSale of shares in Exscientia
17th Jan 20225:56 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSTrading update
11th Jan 20227:00 amRNSCelerum launch first commercial product
9th Dec 20212:33 pmRNSResult of AGM
29th Nov 20217:00 amRNSTVG - milestone in development of COVID-19 vaccine
9th Nov 20217:00 amRNSPosting of Annual Accounts and Notice of AGM
28th Oct 20217:00 amRNSDirectorate Change
28th Oct 20217:00 amRNSFinal Results
15th Oct 20217:00 amRNSPublication of newsletter
1st Oct 20217:59 amRNSPricing of IPO of Exscientia in the United States
30th Sep 20217:00 amRNSCamGraPhIC raises £1.6 million
27th Sep 20213:56 pmRNSUpdate on proposed IPO of Exscientia
24th Sep 20217:00 amRNSHolding(s) in Company
13th Sep 20217:00 amRNSExscientia - Statement filed for proposed IPO
8th Sep 20211:24 pmRNSExscientia enters $70M collaboration
8th Jul 20217:00 amRNSCamGraPhIC loan facility of up to £1.5 million
15th Jun 20217:00 amRNSPulsiv appoints Adam Westcott as CFO
14th Jun 20217:00 amRNSNandi Proteins appoints David Flower as CEO
11th Jun 20217:00 amRNSPublication of newsletter
24th May 20217:00 amRNSPulsiv complete £1.5m fundraising and appoints CEO
19th May 202111:53 amRNSExscientia collaboration with Bristol Myers Squibb
6th May 20217:00 amRNSThe Vaccine Group appoints Jeremy Salt as CEO
30th Apr 20211:58 pmRNSHolding(s) in Company
28th Apr 20217:01 amRNSTrading update
28th Apr 20217:00 amRNSExscientia Series D funding led by SoftBank

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.